Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPR
651
DELISTED
Spirit AeroSystems
SPR
| $16.7M | 0.03% |
346,147
-38,510
| -10% | -$2.05M |
|
652
Globe Life
GL
$13.3B
| $16.7M | 0.03% |
+296,062
| New | +$17.6M |
|
653
CALL
Fluor
FLR
$6.86B
| $16.7M | 0.03% |
+394,200
| New | +$18.5M |
|
654
Ameriprise Financial
AMP
$49.6B
| $16.7M | 0.03% |
152,964
-434,717
| -74% | -$51.3M |
|
655
Rambus
RMBS
$9.44B
| $16.6M | 0.03% |
1,410,198
+1,333,232
| +1,732% | +$17.3M |
|
656
Kilroy Realty
KRC
$4.29B
| $16.5M | 0.03% |
253,153
+133,753
| +112% | +$9.15M |
|
|
RPAI
657
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $16.5M | 0.03% |
1,169,431
+61,363
| +6% | +$879K |
|
658
Northern Trust
NTRS
$34.2B
| $16.5M | 0.03% |
241,652
-38,297
| -14% | -$2.81M |
|
659
Leidos
LDOS
$17.4B
| $16.4M | 0.03% |
395,884
+331,322
| +513% | +$13.8M |
|
660
ICU Medical
ICUI
$4.57B
| $16.3M | 0.03% |
149,160
+47,258
| +46% | +$5.06M |
|
|
GES
661
DELISTED
Guess Inc
GES
| $16.2M | 0.03% |
759,561
-280,746
| -27% | -$6.08M |
|
|
HNT
662
DELISTED
HEALTH NET INC
HNT
| $16.2M | 0.03% |
269,066
-68,247
| -20% | -$4.52M |
|
|
SYNH
663
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $16.1M | 0.03% |
403,641
+249,058
| +161% | +$10.9M |
|
664
The Greenbrier Companies
GBX
$1.43B
| $16.1M | 0.03% |
501,000
+399,428
| +393% | +$16.8M |
|
665
Omeros
OMER
$1.4B
| $16.1M | 0.03% |
1,466,973
+1,440,195
| +5,378% | +$22.4M |
|
666
NetEase
NTES
$78.7B
| $16.1M | 0.03% |
669,215
-755,395
| -53% | -$19.5M |
|
667
Deluxe
DLX
$1.1B
| $16.1M | 0.03% |
288,132
+111,632
| +63% | +$6.73M |
|
668
Travel + Leisure Co
TNL
$4.48B
| $16M | 0.03% |
493,234
+395,384
| +404% | +$14.2M |
|
669
RH
RH
$2.71B
| $15.9M | 0.03% |
+170,882
| New | +$16.8M |
|
|
GOLD
670
DELISTED
Randgold Resources Ltd
GOLD
| $15.9M | 0.03% |
270,453
+194,156
| +254% | +$11.7M |
|
671
Diageo
DEO
$53.4B
| $15.9M | 0.03% |
147,221
+97,221
| +194% | +$10.8M |
|
672
Centene
CNC
$32.4B
| $15.9M | 0.03% |
+584,848
| New | +$19.6M |
|
|
NGHC
673
DELISTED
National General Holdings Corp
NGHC
| $15.8M | 0.03% |
820,310
+468,974
| +133% | +$9.64M |
|
|
PHH
674
DELISTED
PHH Corporation
PHH
| $15.8M | 0.03% |
1,119,496
+113,050
| +11% | +$2.21M |
|
|
HES
675
CALL
DELISTED
Hess
HES
| $15.8M | 0.03% |
+315,300
| New | +$18M |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.